5058 POSTER Randomized Phase II Multicenter Trial of Oral Antiangiogenic Agent TSU-68 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline

Authors:
  • SKS. Kim
    S. Kim
  • JRJ. Ro
    J. Ro
  • YIY.H. Im
    Y.H. Im
  • JKJ.H. Kim
    J.H. Kim
  • HSH.S. Song
    H.S. Song
  • SKS.Y. Kang
    S.Y. Kang
  • HPH.S. Park
    H.S. Park
  • HCH.C. Chung
    H.C. Chung

Abstract
No abstract available